Ozempic 1 MG/dose (4 MG/3 ML) 3ML
Ended Awarded Last action
- Contract number
- SPE2DR26FFJ9L
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $68,560
Award facts
- Contract value 100% obligated
- $68,559.93 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 31, 2025, for the supply of Ozempic 1 mg/dose (4 mg/3 mL) 3 mL vials, with a contract ceiling value of $68,559.93 and an ultimate completion date of January 2, 2026. This is a firm fixed-price delivery order with no set-aside designation, awarded through open competition. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military and federal healthcare systems.
AmerisourceBergen Drug Corp is one of the nation's leading pharmaceutical distributors and holds a significant position as a critical vendor within the DLA Medical Supply Chain. The company supplies a broad portfolio of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including specialty medications, brand-name and generic drugs, and vaccines across multiple therapeutic domains. The Ozempic delivery order reflects the company's role in providing diabetes management medications to federal healthcare systems, including the Defense Health Agency, U.S. Coast Guard, and other government entities. As a child contract under the SPE2DX IDC, this order demonstrates AmerisourceBergen's continued capability to meet federal procurement requirements through its established relationship with DLA.
Quick answers
Who was awarded contract SPE2DR26FFJ9L?
SPE2DR26FFJ9L was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 31, 2025.
How much is contract SPE2DR26FFJ9L worth?
The government has obligated $68,560 on SPE2DR26FFJ9L.
Is contract SPE2DR26FFJ9L an order under another contract?
Yes. SPE2DR26FFJ9L is a delivery order under SPE2DR25D1109, an indefinite delivery contract.
Was contract SPE2DR26FFJ9L competed?
The extent of competition for SPE2DR26FFJ9L was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award